Rt. Franceschi, The developmental control of osteoblast-specific gene expression: Role of specific transcription factors and the extracellular matrix environment, CR R ORAL B, 10(1), 1999, pp. 40-57
Bone formation is a carefully controlled developmental process involving mo
rphogen-mediated patterning signals that define areas of initial mesenchyme
condensation followed by induction of cell-specific differentiation progra
ms to produce chondrocytes and osteoblasts. Positional information is conve
yed via gradients of molecules, such as Sonic Hedgehog that are released fr
om cells within a particular morphogenic field together with region-specifi
c patterns of hox gene expression. These, in turn, regulate the localized p
roduction of bone morphogenetic proteins and related molecules which initia
te chondrocyte- and osteoblast-specific differentiation programs. Different
iation requires the initial commitment of mesenchymal stem cells to a given
lineage, followed by induction of tissue-specific patterns of gene express
ion. Considerable information about the control of osteoblast-specific gene
expression has come from analysis of the promoter regions of genes encodin
g proteins like osteocalcin that are selectively expressed in bone. Both ge
neral and tissue-specific transcription factors control this promoter. Osf2
/Cbfa1, the first osteoblast-specific transcription factor to be identified
, is expressed early in the osteoblast lineage and interacts with specific
DNA sequences in the osteocalcin promoter essential for its selective expre
ssion in osteoblasts. The OSF2/CBFA1 gene is necessary for the development
of mineralized tissues, and its mutation causes the human disease, cleidocr
anial dysplasia. Committed osteoprogenitor cells already expressing Osf2/Cb
fa1 must synthesize a collagenous ECM before they will differentiate. A cel
l ECM interaction mediated by integrin-type cell-surface receptors is essen
tial for the induction of osteocalcin and other osteoblast-related proteins
. This interaction stimulates the binding of Osf2/Cbfa1 to the osteocalcin
promoter through an as-yet-undefined mechanism.